Breakthrough lung cancer drug helps clinical trial patient

March 06, 2015

A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.

OX40 work has reached a new milestone

October 16, 2014
The first patients were treated with the human version in clinical trials, including at Providence Cancer Center.

Dr. Urba honored as ‘cancer warrior’

October 07, 2014
The Oregon Historical Society recognized Walter J. Urba, M.D., Ph.D., as a 2014 Oregon History Maker at its Oct. 5 awards dinner, referencing him as a “cancer warrior.”

Multimillion dollar grant improves access to cancer care and clinical trials

August 07, 2014

Cancer patients in Oregon, Washington and three other Western states will receive improved access to care and clinical trials as a result of a new $6.6 million grant from the National Cancer Institute’s Community Oncology Research Program, or NCORP. 

Clinical trial at Providence Cancer Center could change how doctors treat Leukemia

July 31, 2014

Groundbreaking research at Providence Cancer Center is looking for ways to save the lives of people with leukemia and lymphoma. One local man talks about his choice to participate in a clinical trial to help further the fight against leukemia.

Melanoma survivor credits clinical trial, immunotherapy with saving his life

July 16, 2014

Diagnosed with metastatic melanoma, a local man was facing an early death. Now, seven years later, he’s beating the odds and spreading the word about skin cancer prevention and a clinical trial involving immunotherapy that he credits with saving his life.

Oregon Business Journal: local philanthropy and cancer research

July 16, 2014

Featured in the July issue of the Oregon Business Magazine, Dr. Walter Urba – medical oncologist and director of the Robert W. Franz Center Research Center at Providence Cancer Center – discusses the impact of local philanthropy in cancer research as federal funding continues to decline.

Immunotherapy and Providence Cancer Center featured in Portland Business Journal

July 11, 2014
In the cover story of the July 11, 2014 issue, the Portland Business Journal explores the current state of cancer treatments and the role Portland researchers are playing in new research.

NIH honors Providence scientist with $1.6 million immunotherapy research grant

June 13, 2014

In a significant show of support for immunotherapy research in the treatment of cancer, the National Institutes of Health has awarded a $1.6...

Dr. Crocenzi receives PANCAN award as co-principal investigator

June 02, 2014

Todd Crocezni, M.D., director of gastrointestinal oncology research at the Robert W. Franz Cancer Research Center in the Earle A. Chiles Research...

Providence Brain and Cancer Experts Begin First-In-World Novel Brain Tumor Vaccine Research Trial

May 05, 2014

Fourteen months. That’s the median life expectancy of someone diagnosed with high-grade glioma, the most common primary brain tumor in adults, even with the current standard of treatment. Providence Cancer Center researchers and a Providence Brain and Spine Institute neurosurgeon believe immunotherapy might change that statistic. 

Beating back cancer, cell by cell

February 21, 2014

In 2005, Providence Cancer Center spun off a biotechnology startup to develop and commercialize several promising cancer vaccines and to take...

Outcomes promising in OX40 study at Providence Cancer Center

December 11, 2013

Portland-area researchers have scored promising results in the hottest field in cancer research today: Using the immune system to fight tumors. The results are a victory in an underdog story of achieving results without pharmaceutical company backing. 

Providence studies new therapy for patients with curable breast cancer

October 22, 2013
Providence Cancer Center is the only site in Oregon to open the KATHERINE study (NSABP B-50-I), evaluating the efficacy and safety of trastuzumab emtansine (Kadcyla) versus trastuzumab (Herceptin) as adjuvant (postoperative) therapy for breast cancer.

Providence Cancer Center research intern experienced disease firsthand

August 29, 2013

Ellen Patterson spent her summer as a cancer research intern at Providence Cancer Center after successfully battling ovarian cancer at 15.

Two Astoria teens organize fundraiser run for Providence Cancer Center research

July 16, 2013

Peyton Fischer and Amber Longsdorf, two teens who each have had family and friends who have been affected by cancer, organized "A Step Ahead" 5k charity run and raised $1,207.61 for cancer research.

Providence Cancer Center celebrates 20 years of research

June 15, 2013
Twenty years ago this summer, Providence Health & Services made the decision to begin researching cures for cancer.

Providence Cancer Center first in nation to offer unique trial treatment for lymphoma patients

May 21, 2013

People with B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia have a unique opportunity to participate in groundbreaking research at Providence Cancer Center.

New immunotherapy treatment shows great promise for patients fighting B-cell non-Hodgkin's lymphoma

May 16, 2013

Finding effective treatments for the various types of cancer – it’s the goal of researchers around the world, and right here in Portland. Now Providence Cancer Center is the first site in the nation to test a new immunotherapy treatment that’s showing great promise for patients fighting B-cell non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.

Coordinated care helps cancer patients, Dr. Urba weighs in at Chamber of Medford/Jackson County Forum

May 09, 2013

Active, coordinated care handled by advanced medical teams can make a world of difference for cancer patients or those at risk for cancer.

Providence cancer research gets boost from Fred Meyer shoppers and employees

April 02, 2013

The donation is a result of the store chain's third quarter employee giving campaign and all the coins collected in the checkout lines at Portland area locations.

Innovative treatment for leukemia used to treat young Redmond girl

March 29, 2013

Dr. Walter Urba, director of cancer research for Providence's Robert W. Franz Cancer Research Center, comments on experimental immunotherapy treatment in this article from The Bend Bulletin.

Portland Business Journal reports Providence's cancer team making strides

March 11, 2013

In the past 20 years, Providence has contributed to several significant breakthroughs in cancer research.

Grants provide new support for oral, head and neck cancer research at Providence

February 12, 2013

Providence Cancer Center has ramped up its fight against oral, head and neck cancer with two new research grants totaling more than half a million dollars.

Early-phase clinical trials open new opportunities

January 16, 2013

Providence's involvement with the International Immuno-Oncology Network, along with other early-phase studies, is broadening treatment options for patients with advanced cancers.

Two grants benefit oral cancer research

January 10, 2013

Providence researchers will focus on biomarkers and vaccines to help fight the disease.

Providence Festival of Trees magic brings hope of cancer research miracles

December 29, 2012

For three decades, Providence Festival of Trees has been the premier holiday event in Portland. This year, the 30th anniversary was a true celebration of the season.

Providence cancer research laboratory receives major grants

December 06, 2012

Research scientist Keith Bahjat, Ph.D., recently received two grants supporting work on immunotherapy.

Providence Cancer Center recognized for commitment to quality and excellence

September 28, 2012

Providence is the only cancer facility in Oregon to receive QOPI certification.

News from China on new transformational approach in oncology

September 27, 2012

Bernie Fox, Ph.D., speaks at annual meeting in China about a new approach to determine immune response to tumors.

Providence cancer research: One-two punch offers great hope for metastatic melanoma in clinical trials patients

June 06, 2012

Research at Providence Cancer Center shows a novel combination treatment could offer new hope for patients with advanced melanoma.

Immune therapy may yield long-lasting treatment for many cancers

June 04, 2012

"There is still a long road ahead, but now it's lined with some successes," says Walter Urba, M.D., Ph.D.

Cancer research news

April 26, 2012

Read the latest highlights on our researchers.

Providence cancer research gets a boost with MedImmune agreement

December 02, 2011

The biotech company will fund further OX40 research developed by Providence scientists.

Providence cancer researcher earns two-year award

November 07, 2011

William Redmond, Ph.D., received the 2011 V Scholar Award from The V Foundation for Cancer Research.

Providence selected for nationwide immunotherapy network

October 24, 2011

Providence Cancer Center is among North America's top research institutions invited to join the national Cancer Immunotherapy Trials Network.

Bench to Bedside: Providence Researcher Awarded Funds to Create Cancer-Fighting Protein

June 29, 2011

Providence Cancer Center researcher Andrew Weinberg, Ph.D., recently received a $935,000 grant from the Department of Defense Prostate Cancer Research Program for a study that has the potential to fast track a treatment for prostate cancer patients in as little as five years.

Providence researcher awarded funds to create cancer-fighting protein

June 28, 2011

Department of Defense Prostate Cancer Research Program Grant awarded to Providence Cancer Center researcher Andrew Weinberg, Ph.D.

Providence cancer drug trial wins FDA approval

April 11, 2011

Ipilimumab is the first drug shown to extend survival in patients with late-stage melanoma.